{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:38:24Z","timestamp":1792496304337,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jpainsymman.2007.04.023","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T10:06:31Z","timestamp":1201687591000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fentanyl-Induced Neurotoxicity and Paradoxic Pain"],"prefix":"10.1016","volume":"35","author":[{"given":"Tomasz R.","family":"Okon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathews Lal","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpainsymman.2007.04.023_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/jpm.2000.3.4.449","article-title":"The bedside confusion scale: development of a portable bedside test for confusion and its application to the palliative medicine population","volume":"3","author":"Stillman","year":"2000","journal-title":"J Palliat Med"},{"issue":"6","key":"10.1016\/j.jpainsymman.2007.04.023_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","article-title":"Morphine-3-glucuronide\u2014a potent antagonist of morphine analgesia","volume":"47","author":"Smith","year":"1990","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.04.023_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0304-3959(91)90225-M","article-title":"Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine","volume":"47","author":"De Conno","year":"1991","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jpainsymman.2007.04.023_bib4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000542-199510000-00027","article-title":"Epidural and intravenous opioid-induced neuroexcitation","volume":"83","author":"Rozan","year":"1995","journal-title":"Anesthesiology"},{"issue":"2\u20133","key":"10.1016\/j.jpainsymman.2007.04.023_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0304-3959(97)00173-5","article-title":"Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus","volume":"75","author":"Kronenberg","year":"1998","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.jpainsymman.2007.04.023_bib6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1399-6576.1998.tb05378.x","article-title":"Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories","volume":"42","author":"Sj\u00f6gren","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.jpainsymman.2007.04.023_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0885-3924(02)00531-6","article-title":"Relationships among morphine metabolism, pain and side effects during long-term treatment: an update","volume":"25","author":"Andersen","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists","volume":"59","author":"Sj\u00f6gren","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpainsymman.2007.04.023_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0885-3924(97)00001-8","article-title":"Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies","volume":"14","author":"Hagen","year":"1997","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.jpainsymman.2007.04.023_bib10","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2007.04.023_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/104990910502200411","article-title":"Hyperalgesia and opioid switching","volume":"22","author":"Mercadante","year":"2005","journal-title":"Am J Hosp Palliat Care"},{"issue":"1\u20132","key":"10.1016\/j.jpainsymman.2007.04.023_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(96)03238-1","article-title":"Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain","volume":"69","author":"Bruera","year":"1997","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00008506-199704000-00007","article-title":"Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain","volume":"9","author":"Devulder","year":"1997","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2007.04.023_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0196-0644(96)70205-6","article-title":"Fentanyl neurotoxicity","volume":"27","author":"Adair","year":"1996","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.04.023_bib15","first-page":"239","article-title":"Pharmacodynamics, pharmacokinetics, and clinical uses of fentanyl, sufentanil, and alfentanil","volume":"22","author":"Willens","year":"1993","journal-title":"Heart Lung"},{"issue":"6108","key":"10.1016\/j.jpainsymman.2007.04.023_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.1.6108.278","article-title":"Delayed respiratory depression after use of fentanyl during anaesthesia","volume":"1","author":"Adams","year":"1978","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0773.1994.tb00327.x","article-title":"Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites","volume":"75","author":"Bartlett","year":"1994","journal-title":"Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","article-title":"Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain","volume":"17","author":"Quigley","year":"2003","journal-title":"Palliat Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.04.023_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"issue":"1-2","key":"10.1016\/j.jpainsymman.2007.04.023_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0169-328X(00)00260-6","article-title":"A murine model of opioid-induced hyperalgesia","volume":"86","author":"Li","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.102.035626","article-title":"Morphine-3beta-D-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa","volume":"302","author":"Moran","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3565(25)24481-0","article-title":"Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine","volume":"244","author":"Yaksh","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2003.09.068","article-title":"Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice","volume":"995","author":"Crain","year":"2004","journal-title":"Brain Res"},{"issue":"6626","key":"10.1016\/j.jpainsymman.2007.04.023_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/386721a0","article-title":"NMDA-receptor regulation of substance P release from primary afferent nociceptors","volume":"386","author":"Liu","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine","volume":"92","author":"C\u00e9l\u00e8rier","year":"2000","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.04.023_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(94)90171-6","article-title":"Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011","volume":"252","author":"Lufty","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.jpainsymman.2007.04.023_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(03)00276-8","article-title":"Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal","volume":"106","author":"Angst","year":"2003","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.jpainsymman.2007.04.023_bib28","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1523\/JNEUROSCI.21-11-04074.2001","article-title":"Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process","volume":"21","author":"C\u00e9l\u00e8rier","year":"2001","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.04.023_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200008000-00019","article-title":"Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement","volume":"93","author":"Guignard","year":"2000","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.04.023_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3959(95)00073-2","article-title":"Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions","volume":"62","author":"Mao","year":"1995","journal-title":"Pain"},{"issue":"2\u20133","key":"10.1016\/j.jpainsymman.2007.04.023_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(96)03225-3","article-title":"Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone","volume":"68","author":"Vanderah","year":"1996","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.jpainsymman.2007.04.023_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2005.06.030","article-title":"Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model","volume":"118","author":"Koppert","year":"2005","journal-title":"Pain"},{"issue":"15","key":"10.1016\/j.jpainsymman.2007.04.023_bib33","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002","article-title":"Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers","volume":"22","author":"Gardell","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.jpainsymman.2007.04.023_bib34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00000542-200605000-00023","article-title":"A genetic analysis of opioid-induced hyperalgesia in mice","volume":"104","author":"Liang","year":"2006","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.jpainsymman.2007.04.023_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajmg.b.30324","article-title":"Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder","volume":"141","author":"Diatchenko","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"10.1016\/j.jpainsymman.2007.04.023_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0022-3565(24)36410-9","article-title":"Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor","volume":"280","author":"Ammer","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.jpainsymman.2007.04.023_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM199403033300902","article-title":"Pain and its treatment in outpatients with metastatic cancer","volume":"330","author":"Cleeland","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2007.04.023_bib38","author":"National Comprehensive Cancer Network (NCCN)"},{"issue":"1","key":"10.1016\/j.jpainsymman.2007.04.023_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpainsymman.2003.11.005","article-title":"The hidden error of mismanaged pain: a systems approach","volume":"28","author":"McNeill","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"13","key":"10.1016\/j.jpainsymman.2007.04.023_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jpainsymman.2007.04.023_bib41","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407007324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407007324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:59:27Z","timestamp":1760129967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392407007324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0885392407007324"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.04.023","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl-Induced Neurotoxicity and Paradoxic Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}